Author Correction: Personalized cancer vaccine strategy elicits polyfunctional T cells and demonstrates clinical benefits in ovarian cancer

• Janos L. Tanyi,
• Cheryl L.-L. Chiang,
• Johanna Chiffelle,
• Anne-Christine Thierry,
• Petra Baumgartener,
• Florian Huber,
• Christine Goepfert,
• David Tarussio,
• Stephanie Tissot,
• Drew A. Torigian,
• Harvey L. Nisenbaum,
• Brian J. Stevenson,
• Hajer Fritah Guiren,
• Ritaparna Ahmed,
• Anne-Laure Huguenin-Bergenat,
• Emese Zsiros,
• Michal Bassani-Sternberg,
• Rosemarie Mick,
• Daniel J. Powell,
• George Coukos,
• Alexandre Harari,
• Lana E. Kandalaft

Affiliations

Janos L. Tanyi

Ovarian Cancer Research Center, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania

Cheryl L.-L. Chiang

Department of Oncology, Lausanne University Hospital (CHUV), Ludwig Institute for Cancer Research, University of Lausanne

Johanna Chiffelle

Department of Oncology, Lausanne University Hospital (CHUV), Ludwig Institute for Cancer Research, University of Lausanne

Anne-Christine Thierry

Center of Experimental Therapeutics, Department of Oncology, Lausanne University Hospital (CHUV)

Petra Baumgartener

Center of Experimental Therapeutics, Department of Oncology, Lausanne University Hospital (CHUV)

Florian Huber

Department of Oncology, Lausanne University Hospital (CHUV), Ludwig Institute for Cancer Research, University of Lausanne

Christine Goepfert

Institute of Animal Pathology, COMPATH, Vetsuisse Faculty, University of Bern

David Tarussio

Center of Experimental Therapeutics, Department of Oncology, Lausanne University Hospital (CHUV)

Stephanie Tissot

Center of Experimental Therapeutics, Department of Oncology, Lausanne University Hospital (CHUV)

Drew A. Torigian

Department of Radiology, Hospital of the University of Pennsylvania

Harvey L. Nisenbaum

Department of Radiology, Hospital of the University of Pennsylvania

Brian J. Stevenson

Department of Oncology, Lausanne University Hospital (CHUV), Ludwig Institute for Cancer Research, University of Lausanne

Hajer Fritah Guiren

Department of Oncology, Lausanne University Hospital (CHUV), Ludwig Institute for Cancer Research, University of Lausanne

Ritaparna Ahmed

Department of Oncology, Lausanne University Hospital (CHUV), Ludwig Institute for Cancer Research, University of Lausanne

Anne-Laure Huguenin-Bergenat

Department of Oncology, Lausanne University Hospital (CHUV), Ludwig Institute for Cancer Research, University of Lausanne

Emese Zsiros

Ovarian Cancer Research Center, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania

Michal Bassani-Sternberg

Department of Oncology, Lausanne University Hospital (CHUV), Ludwig Institute for Cancer Research, University of Lausanne

Rosemarie Mick

Department of Biostatistics and Epidemiology, Perelman School of Medicine, University of Pennsylvania

Daniel J. Powell

Ovarian Cancer Research Center, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania

George Coukos

Department of Oncology, Lausanne University Hospital (CHUV), Ludwig Institute for Cancer Research, University of Lausanne

Alexandre Harari

Department of Oncology, Lausanne University Hospital (CHUV), Ludwig Institute for Cancer Research, University of Lausanne

Lana E. Kandalaft

Department of Oncology, Lausanne University Hospital (CHUV), Ludwig Institute for Cancer Research, University of Lausanne